Literature DB >> 19149821

Problematic heroin use incidence trends in Spain.

Albert Sánchez-Niubò1, Josep Fortiana, Gregorio Barrio, Josep Maria Suelves, Juan Francisco Correa, Antònia Domingo-Salvany.   

Abstract

AIMS: To estimate the annual incidence of heroin use in Spain. PARTICIPANTS AND
DESIGN: Data on individuals' year of first heroin use (from 1971 to 2005), year of first heroin treatment between 1991 and 2005 and most frequent route of heroin administration when presenting to treatment were obtained from the Spanish Drug Observatory Register and used to calculate the delay between onset and treatment. By using a log-linear model approach it was possible to correct for missing observations (heroin users who presented for treatment before 1991 and those who had still not presented by the end of 2005) and to estimate heroin incidence over time.
FINDINGS: The estimated incidence of problematic heroin use in the population aged 15-44 peaked at 190 per 100,000 in 1980--after rising rapidly from less than 40 per 100,000 in 1971--and fell subsequently to about 8 per 100,000 in 2005. On average, incidence was five times higher in men. Injecting heroin incidence peaked and declined rapidly from 1980; as heroin smoking did not decline as rapidly, from 1985 onwards its estimated incidence has remained above that of heroin injecting. The delay between starting heroin use and entering treatment had a median of 3 years.
CONCLUSIONS: We demonstrate the utility of a method to estimate heroin incidence from analysis of observed trends in presentations at specialist drug treatment facilities. The estimates suggest that incidence of heroin use, especially injecting, has fallen since 1980 and is now lower than in the early 1970s.

Entities:  

Mesh:

Year:  2009        PMID: 19149821     DOI: 10.1111/j.1360-0443.2008.02451.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  7 in total

1.  Estimation of the Number of People With Opioid Addiction in Germany.

Authors:  Ludwig Kraus; Nicki-Nils Seitz; Bernd Schulte; Peter Cremer-Schaeffer; Barbara Braun; Uwe Verthein; Tim Pfeiffer-Gerschel
Journal:  Dtsch Arztebl Int       Date:  2019-03-01       Impact factor: 5.594

2.  Methadone maintenance treatment in Spain: the success of a harm reduction approach.

Authors:  Marta Torrens; Francina Fonseca; Claudio Castillo; Antonia Domingo-Salvany
Journal:  Bull World Health Organ       Date:  2013-02-01       Impact factor: 9.408

3.  An exploration of alcohol use severity and route of drug administration among persons that use heroin and cocaine.

Authors:  Michael Scherer; Paul T Harrell; Rebecca C Trenz; Sarah Canham; William W Latimer
Journal:  Subst Abus       Date:  2015-11-13       Impact factor: 3.716

4.  Evolution of acute hepatitis C virus infection in a large European city: Trends and new patterns.

Authors:  César Garriga; Sandra Manzanares-Laya; Patricia García de Olalla; Pilar Gorrindo; Sabela Lens; Ricard Solà; María Martínez-Rebollar; Montserrat Laguno; Jordi Navarro; Xavier Torras; Mercè Gurguí; María-Jesús Barberá; Josep Quer; Eva Masdeu; Pere Simón; Miriam Ros; Anna de Andrés; Joan A Caylà
Journal:  PLoS One       Date:  2017-11-14       Impact factor: 3.240

5.  Sexualized drug injection among men who have sex with men in Madrid and Barcelona as the first episode of drug injecting.

Authors:  Juan-Miguel Guerras; Patricia García de Olalla; María José Belza; Luis de la Fuente; David Palma; Jorge Del Romero; Jorge-Néstor García-Pérez; Juan Hoyos
Journal:  Harm Reduct J       Date:  2021-08-06

6.  Estimating the Prevalence of Recreational Opioid Use in Spain Using a Multiplier Method.

Authors:  José Pulido; Albert Sanchez-Niubo; Noelia Llorens; Juan Hoyos; Gregorio Barrio; Maria Jose Belza; Lucía Cea-Soriano; Ariadna Angulo-Brunet; Luis Sordo
Journal:  Int J Environ Res Public Health       Date:  2022-04-15       Impact factor: 3.390

7.  A multi-state model to estimate incidence of heroin use.

Authors:  Albert Sánchez-Niubò; Odd O Aalen; Antònia Domingo-Salvany; Ellen J Amundsen; Josep Fortiana; Kjetil Røysland
Journal:  BMC Med Res Methodol       Date:  2013-01-14       Impact factor: 4.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.